<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1137" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1137/" /><meta name="ncbi_pagename" content="Cherubism - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Cherubism - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Cherubism" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/11/21" /><meta name="citation_author" content="Peter Kannu" /><meta name="citation_author" content="Berivan Baskin" /><meta name="citation_author" content="Sarah Bowdin" /><meta name="citation_pmid" content="20301316" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1137/" /><meta name="citation_keywords" content="SH3 domain-binding protein 2" /><meta name="citation_keywords" content="SH3BP2" /><meta name="citation_keywords" content="Cherubism" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Cherubism" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Peter Kannu" /><meta name="DC.Contributor" content="Berivan Baskin" /><meta name="DC.Contributor" content="Sarah Bowdin" /><meta name="DC.Date" content="2018/11/21" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1137/" /><meta name="description" content="Cherubism is a childhood-onset, autoinflammatory bone disease characterized by bilateral and symmetric proliferative fibroosseous lesions limited to the mandible and maxilla. The enlargement is usually symmetric in nature. The phenotype ranges from no clinical manifestations to severe mandibular and maxillary overgrowth with respiratory, vision, speech, and swallowing problems. In most affected persons, teeth are displaced, unerupted, unformed, or absent, or may appear to be floating in cystlike spaces; malocclusion, premature exfoliation of deciduous teeth, and root resorption have also been reported. The course and duration of the active process of bone destruction varies between affected individuals; the onset is usually in early childhood, and typically new lesions can occur until puberty. Regression of the lesions occurs as they become filled with bone and remodel during the second and third decade of life. By age 30 years, the facial abnormalities associated with cherubism are not usually recognizable and residual deformity of the jaws is rare. Typically, cherubism is an isolated benign condition; the affected person has normal intellectual skills and is without other physical anomalies." /><meta name="og:title" content="Cherubism" /><meta name="og:type" content="book" /><meta name="og:description" content="Cherubism is a childhood-onset, autoinflammatory bone disease characterized by bilateral and symmetric proliferative fibroosseous lesions limited to the mandible and maxilla. The enlargement is usually symmetric in nature. The phenotype ranges from no clinical manifestations to severe mandibular and maxillary overgrowth with respiratory, vision, speech, and swallowing problems. In most affected persons, teeth are displaced, unerupted, unformed, or absent, or may appear to be floating in cystlike spaces; malocclusion, premature exfoliation of deciduous teeth, and root resorption have also been reported. The course and duration of the active process of bone destruction varies between affected individuals; the onset is usually in early childhood, and typically new lesions can occur until puberty. Regression of the lesions occurs as they become filled with bone and remodel during the second and third decade of life. By age 30 years, the facial abnormalities associated with cherubism are not usually recognizable and residual deformity of the jaws is rare. Typically, cherubism is an isolated benign condition; the affected person has normal intellectual skills and is without other physical anomalies." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1137/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cherubism/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1137/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89303FDFC89A4100000000054E026C.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1137_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1137_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/chediak-higashi/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cach/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1137_"><span class="title" itemprop="name">Cherubism</span></h1><p class="contrib-group"><span itemprop="author">Peter Kannu</span>, MB ChB, PhD, DCH, FRACP, FRCPC, <span itemprop="author">Berivan Baskin</span>, PhD, FCCMG, FACMG, and <span itemprop="author">Sarah Bowdin</span>, BM, MSc, MRCPCH.</p><a data-jig="ncbitoggler" href="#__NBK1137_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1137_ai__"><div class="contrib half_rhythm"><span itemprop="author">Peter Kannu</span>, MB ChB, PhD, DCH, FRACP, FRCPC<div class="affiliation small">Division of Clinical and Metabolic Genetics<br />The Hospital for Sick Children and Peter Gilgan Centre for Research and Learning<br />Toronto, Ontario, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.sdikkcis@unnak.retep" class="oemail">ac.sdikkcis@unnak.retep</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Berivan Baskin</span>, PhD, FCCMG, FACMG<div class="affiliation small">Clinical Genetics<br />Uppsala University Hospital<br />Uppsala, Sweden<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="es.aksimedaka@niksab.navireb" class="oemail">es.aksimedaka@niksab.navireb</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Sarah Bowdin</span>, BM, MSc, MRCPCH<div class="affiliation small">East Anglia Medical Genetics Service<br />Addenbrooke's Hospital<br />Cambridge, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.shn.sekoorbnedda@nidwob.haras" class="oemail">ku.shn.sekoorbnedda@nidwob.haras</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 26, 2007</span>; Last Update: <span itemprop="dateModified">November 21, 2018</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cherubism.Summary" itemprop="description"><h2 id="_cherubism_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Cherubism is a childhood-onset, autoinflammatory bone disease characterized by bilateral and symmetric proliferative fibroosseous lesions limited to the mandible and maxilla. The enlargement is usually symmetric in nature. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> ranges from no clinical manifestations to severe mandibular and maxillary overgrowth with respiratory, vision, speech, and swallowing problems. In most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> persons, teeth are displaced, unerupted, unformed, or absent, or may appear to be floating in cystlike spaces; malocclusion, premature exfoliation of deciduous teeth, and root resorption have also been reported. The course and duration of the active process of bone destruction varies between affected individuals; the onset is usually in early childhood, and typically new lesions can occur until puberty. Regression of the lesions occurs as they become filled with bone and remodel during the second and third decade of life. By age 30 years, the facial abnormalities associated with cherubism are not usually recognizable and residual deformity of the jaws is rare. Typically, cherubism is an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> benign condition; the affected person has normal intellectual skills and is without other physical anomalies.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Diagnosis is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical, radiographic, and histologic findings and/or a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SH3BP2</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Given that cherubism is considered to be a self-limited condition that improves over time, treatment should be tailored to the individual's presentation and the evolution of the disease. Ongoing management by a craniofacial team in a major pediatric medical center is recommended; depending on the severity, surgery may be needed for functional and esthetic concerns.</p><p><i>Surveillance:</i> Long-term follow up with clinical, radiographic, dental, orthodontic, and ophthalmologic evaluations. Annual reviews are indicated while new cysts continue to form or established cysts enlarge; after the disorder becomes quiescent, follow up every two to five years.</p><p><i>Testing of relatives at risk</i>: When the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known, molecular testing can be used to identify mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> relatives who may benefit from early intervention; otherwise, clinical and radiographic evaluations can identify relatives at risk.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Cherubism is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The proportion of cases caused by <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants is unknown because of <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> and reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. Each child of an individual with cherubism has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Prenatal diagnosis for pregnancies at increased risk and preimplantation diagnosis are possible if the pathogenic variant has been identified in the family.</p></div></div><div id="cherubism.Diagnosis"><h2 id="_cherubism_Diagnosis_">Diagnosis</h2><p>Cherubism is a childhood-onset, autoinflammatory bone disease characterized by bilateral and symmetric proliferative fibroosseous lesions limited to the mandible and maxilla. The course and duration of the active process of bone destruction varies between <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals; the onset is usually in early childhood, and typically new lesions can occur until puberty. Regression of the lesions occurs as they become filled with bone and remodel during the second and third decade of life. No formal clinical diagnostic criteria for cherubism have been published to date.</p><p>Some experts consider a tissue biopsy sufficient to confirm the diagnosis. However, since cherubic phenotypes can be mimicked by other jaw tumors requiring different therapeutic strategies, a thoughtful consideration of histologic analysis is warranted [<a class="bk_pop" href="#cherubism.REF.friedrich.2016.3109">Friedrich et al 2016</a>].</p><div id="cherubism.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Cherubism <b>should be suspected</b> in individuals with the following clinical, radiologic, and histologic findings.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Onset usually between age two and seven years</div></li><li class="half_rhythm"><div>Bilateral, symmetric enlargement of the mandible and/or maxilla including coronoids but usually sparing the condyles. Other cranial bones are usually unaffected.</div></li><li class="half_rhythm"><div>Swelling of submandibular and cervical lymph nodes (early in the course only)</div></li><li class="half_rhythm"><div>Slow progression of the jaw lesions up to adolescence and spontaneous regression typically starting after puberty and extending into the twenties</div></li><li class="half_rhythm"><div>Upturned tilting of eyeballs (in advanced stages); rim of sclera visible beneath iris</div></li><li class="half_rhythm"><div>Dental abnormalities: congenitally missing second and third molars; premature exfoliation of the deciduous teeth and displacement of permanent teeth secondary to the jaw lesions; malocclusion</div></li></ul><p><b>Radiographic manifestations</b> typically include bilateral, multilocular, radiolucent areas within the mandible, usually located at the angles and rami. The coronoid processes are commonly involved, whereas the condyles are rarely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><ul><li class="half_rhythm"><div>Lesions in the mandible are usually symmetric, whereas those in the maxilla may be asymmetric.</div></li><li class="half_rhythm"><div>Imaging typically shows expansile remodeling of the involved bones, thinning of the cortices, and multilocular radiolucencies with a coarse trabecular pattern [<a class="bk_pop" href="#cherubism.REF.beaman.2004.1051">Beaman et al 2004</a>].</div></li></ul><p><b>Histologic manifestations</b> of lesions in the mandible and/or maxilla: non-neoplastic fibrotic lesions that contain numerous multinuclear giant cells and occasionally cysts. Increase in osteoid and newly formed bone matrix is observed in the periphery. Since cherubic phenotypes can be mimicked by other jaw tumors requiring different therapeutic strategies, a thoughtful consideration of histological analysis is required [<a class="bk_pop" href="#cherubism.REF.friedrich.2016.3109">Friedrich et al 2016</a>].</p></div><div id="cherubism.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of cherubism <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical, radiographic, and histologic findings and/or a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SH3BP2</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1137/table/cherubism.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figcherubismTmoleculargenetictestingus" rid-ob="figobcherubismTmoleculargenetictestingus">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of cherubism overlaps other conditions with jaw lesions, individuals with the distinctive findings described in <a href="#cherubism.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#cherubism.Option_1">Option 1</a>), whereas those with a phenotype indistinguishable from many other inherited disorders with jaw lesions or those in whom the diagnosis of cherubism has not been considered are more likely to be diagnosed using comprehensive genomic testing (see <a href="#cherubism.Option_2">Option 2</a>).</p><div id="cherubism.Option_1"><h4>Option 1</h4><p>When the phenotypic findings suggest the diagnosis of cherubism, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>SH3BP2</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> could be considered, but since cherubism occurs through a <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> mechanism and large intragenic deletion or duplication has not been reported, testing for intragenic deletions or duplication is unlikely to identify a disease-causing variant.</div><div class="half_rhythm"><b>Note:</b> The majority of disease-associated variants have been reported in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 9.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SH3BP2</i> and other genes of interest (see <a href="#cherubism.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="cherubism.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited disorders characterized by jaw lesions or the diagnosis of cherubism is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is the most commonly used genomic testing method; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="cherubism.T.molecular_genetic_testing_us" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Cherubism</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1137/table/cherubism.T.molecular_genetic_testing_us/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cherubism.T.molecular_genetic_testing_us_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cherubism.T.molecular_genetic_testing_us_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_cherubism.T.molecular_genetic_testing_us_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_cherubism.T.molecular_genetic_testing_us_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_cherubism.T.molecular_genetic_testing_us_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SH3BP2</i></td><td headers="hd_h_cherubism.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_cherubism.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~80%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_cherubism.T.molecular_genetic_testing_us_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_cherubism.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_cherubism.T.molecular_genetic_testing_us_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td><td headers="hd_h_cherubism.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_cherubism.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cherubism.TF.1.1"><p class="no_margin">See <a href="/books/NBK1137/#cherubism.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="cherubism.TF.1.2"><p class="no_margin">See <a href="#cherubism.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="cherubism.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="cherubism.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#cherubism.REF.ueki.2001.125">Ueki et al [2001]</a></p></div></dd><dt>5. </dt><dd><div id="cherubism.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="cherubism.TF.1.6"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available. Cherubism occurs through a <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> mechanism; therefore, large intragenic deletions or duplications are unlikely to cause disease.</p></div></dd><dt>7. </dt><dd><div id="cherubism.TF.1.7"><p class="no_margin">Failure to identify a <i>SH3BP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in 20% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals suggests possible genetic heterogeneity [<a class="bk_pop" href="#cherubism.REF.reichenberger.2012.s5">Reichenberger et al 2012</a>].</p></div></dd></dl></div></div></div></div></div></div><div id="cherubism.Clinical_Characteristics"><h2 id="_cherubism_Clinical_Characteristics_">Clinical Characteristics</h2><div id="cherubism.Clinical_Description"><h3>Clinical Description</h3><p>Findings associated with cherubism range from clinically unrecognized features to severe mandibular and maxillary overgrowth with dental, orbital/ophthalmologic, respiratory, speech, and swallowing complications [<a class="bk_pop" href="#cherubism.REF.roginsky.2009.218">Roginsky et al 2009</a>]. Massive enlargement of the jaws is common and can also be associated with severe pain [<a class="bk_pop" href="#cherubism.REF.battaglia.2000.573">Battaglia et al 2000</a>, <a class="bk_pop" href="#cherubism.REF.timo_ca.2000.336">Timo&#x0015f;ca et al 2000</a>, <a class="bk_pop" href="#cherubism.REF.silva.2002.45">Silva et al 2002</a>, <a class="bk_pop" href="#cherubism.REF.gomes.2005.313">Gomes et al 2005</a>, <a class="bk_pop" href="#cherubism.REF.wang.2006.322">Wang et al 2006</a>].</p><p>Wide variability in facial involvement within the same family was reported in the initial family described and in subsequent case series [<a class="bk_pop" href="#cherubism.REF.jones.1950.334">Jones et al 1950</a>, <a class="bk_pop" href="#cherubism.REF.li.2006.84">Li &#x00026; Yu 2006</a>, <a class="bk_pop" href="#cherubism.REF.preda.2010.87">Preda et al 2010</a>, <a class="bk_pop" href="#cherubism.REF.stoor.2017.1806">Stoor et al 2017</a>].</p><p><b>Onset and course.</b> Individuals with cherubism have a normal appearance at birth. Usually, cherubism manifests in early childhood (age 2-7 years) and progresses until puberty, when it begins to stabilize and starts to regress. By age 30 years, the facial abnormalities associated with cherubism are not usually recognizable and residual deformity of the jaws is rare [<a class="bk_pop" href="#cherubism.REF.von_wowern.2000.765">Von Wowern 2000</a>].</p><p><b>Presentation.</b> The disease starts with rapid bone degradation, usually restricted to the mandibular and maxillary regions, and leads to multiple symmetric cystic changes. These cysts are filled with fibrous tissue mass that consists of stromal cells and osteoclast-like cells, resulting in the typical facial <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#cherubism.REF.ozkan.2003.1005">Ozkan et al 2003</a>].</p><ul><li class="half_rhythm"><div>Submandibular and cervical lymph nodes are enlarged during the early stages of cherubism, and may present before the recognition of bony lesions.</div></li><li class="half_rhythm"><div>Mandibular cherubism is more frequent than maxillary [<a class="bk_pop" href="#cherubism.REF.schultzemosgau.2003.201">Schultze-Mosgau et al 2003</a>].</div></li><li class="half_rhythm"><div>Aside from the facial anomalies described, cherubism is an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> benign condition; the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> person has normal intellectual skills and is without other physical anomalies. The following rare exceptions have been reported:</div><ul><li class="half_rhythm"><div>Lesions affecting the temporal bone, ribs, and humerus [<a class="bk_pop" href="#cherubism.REF.wayman.1978.47">Wayman 1978</a>, <a class="bk_pop" href="#cherubism.REF.davis.1983.119">Davis et al 1983</a>, <a class="bk_pop" href="#cherubism.REF.fonseca.2004.75">Fonseca et al 2004</a>]</div></li><li class="half_rhythm"><div>A case of cherubism associated with spondyloarthropathy [<a class="bk_pop" href="#cherubism.REF.ling.2015.681">Ling et al 2015</a>]</div></li></ul></li></ul><p><b>Pathology of lesions.</b> NFATc1 immunohistochemistry on lesional tissue may be helpful in defining a more aggressive form of the disease [<a class="bk_pop" href="#cherubism.REF.kadlub.2016.62">Kadlub et al 2016</a>]. The fibroosseous lesions in cherubism are limited to the mandible and maxilla, but the bone inflammatory findings are similar to other autoinflammatory syndromes with bone involvement, such as chronic recurrent multifocal osteomyelitis (CRMO) and deficiency of interleukin-1 receptor antagonist [<a class="bk_pop" href="#cherubism.REF.wipff.2011.555">Wipff et al 2011</a>, <a class="bk_pop" href="#cherubism.REF.morbach.2013.185">Morbach et al 2013</a>, <a class="bk_pop" href="#cherubism.REF.kadlub.2015.878">Kadlub et al 2015</a>, <a class="bk_pop" href="#cherubism.REF.badermeunier.2018.606">Bader-Meunier et al 2018</a>]. One main difference in the pathology of cherubism, when compared to CRMO, is the degree of osteolysis, which is significantly more profound in cherubism [<a class="bk_pop" href="#cherubism.REF.wipff.2011.555">Wipff et al 2011</a>].</p><p><b>Complications</b> of cherubism may include the following:</p><ul><li class="half_rhythm"><div><b>Jaw.</b> Severe malformation of the jaw may impede physical functions such as chewing and swallowing, and may affect the social and psychological well-being of the individual, therefore forcing a decision on surgery [<a class="bk_pop" href="#cherubism.REF.pontes.2007.831">Pontes et al 2007</a>, <a class="bk_pop" href="#cherubism.REF.papadaki.2012.s6">Papadaki et al 2012</a>, <a class="bk_pop" href="#cherubism.REF.wright.2017.j4068">Wright 2017</a>]. See <a href="#cherubism.Treatment_of_Manifestations">Treatment of Manifestations</a>.</div><ul><li class="half_rhythm"><div>Recurrence of the jaw lesions is possible after surgery.</div></li><li class="half_rhythm"><div>Although the cherubic appearance of patients is expected to be reduced due to involution of the bubble-like distensions of the jaws in early adulthood, this may not be the case for all [<a class="bk_pop" href="#cherubism.REF.redfors.2013.20130034">Redfors et al 2013</a>].</div></li><li class="half_rhythm"><div>The facial disfigurement in cherubism can affect an individual's feelings of self-worth and be the source of bullying. However, a recent Scandinavian study reported that persons with cherubism were psychosocially well adapted and enjoyed a good quality of life [<a class="bk_pop" href="#cherubism.REF.prescott.2013.131">Prescott et al 2013</a>].</div></li><li class="half_rhythm"><div>Difficulties with pronunciation have not been reported as a significant problem [<a class="bk_pop" href="#cherubism.REF.prescott.2013.131">Prescott et al 2013</a>].</div></li></ul></li><li class="half_rhythm"><div><b>Pain.</b> An ache in the mouth and discomfort when eating food are frequently reported [<a class="bk_pop" href="#cherubism.REF.prescott.2013.131">Prescott et al 2013</a>].</div></li><li class="half_rhythm"><div><b>Dental.</b> In most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> persons, teeth are displaced, unerupted, unformed, or absent, or may appear to be floating in cystlike spaces. Malocclusion, premature exfoliation of deciduous teeth, and root resorption have also been reported [<a class="bk_pop" href="#cherubism.REF.kozakiewicz.2001.123">Kozakiewicz et al 2001</a>, <a class="bk_pop" href="#cherubism.REF.stoor.2017.1806">Stoor et al 2017</a>].</div></li><li class="half_rhythm"><div><b>Respiratory.</b> Respiratory problems can include obstructive sleep apnea and upper airway obstruction caused by backward displacement of the tongue [<a class="bk_pop" href="#cherubism.REF.battaglia.2000.573">Battaglia et al 2000</a>, <a class="bk_pop" href="#cherubism.REF.ladhani.2003.552">Ladhani et al 2003</a>, <a class="bk_pop" href="#cherubism.REF.khirani.2013.927">Khirani et al 2013</a>].</div></li><li class="half_rhythm"><div><b>Orbital and ophthalmologic.</b> Ophthalmic manifestations of cherubism vary greatly depending on the level of involvement of the maxilla [<a class="bk_pop" href="#cherubism.REF.mirmohammadsadeghi.2015.33">Mirmohammadsadeghi et al 2015</a>, <a class="bk_pop" href="#cherubism.REF.yoo.2015.70">Yoo et al 2015</a>]. In rare instances, enlargement of the maxilla and penetration of the stromal mass into the orbital floor can cause lower lid retraction, proptosis, strabismus, diplopia, globe displacement, and/or visual loss as a result of optic atrophy, retinal vein occlusion, and macular folds with scarring [<a class="bk_pop" href="#cherubism.REF.carroll.2001.38">Carroll &#x00026; Sullivan 2001</a>, <a class="bk_pop" href="#cherubism.REF.font.2003.1846">Font et al 2003</a>]. Prior reports of patients with maxillary involvement leading to orbital mass effect have varied in their ophthalmic sequelae and age of occurrence, with occurrence ranging from age seven to 27 years [<a class="bk_pop" href="#cherubism.REF.colombo.2001.1884">Colombo et al 2001</a>, <a class="bk_pop" href="#cherubism.REF.ahmadi.2003.570">Ahmadi et al 2003</a>]</div></li></ul></div><div id="cherubism.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>/<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations have been described for cherubism.</p></div><div id="cherubism.Penetrance"><h3>Penetrance</h3><p>Penetrance has not been systematically studied in cherubism. A previous report of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in females compared to males [<a class="bk_pop" href="#cherubism.REF.anderson.1962.5">Anderson &#x00026;McClendon 1962</a>] was subsequently shown to have bias in terms of how unaffected status was ascribed to the adult females [<a class="bk_pop" href="#cherubism.REF.reichenberger.2012.s5">Reichenberger et al 2012</a>].</p></div><div id="cherubism.Nomenclature"><h3>Nomenclature</h3><p>Cherubism was first described as "<a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> multilocular cystic disease of the jaws" by <a class="bk_pop" href="#cherubism.REF.jones.1933.946">Jones [1933]</a>; however, shortly thereafter he renamed the condition "cherubism" because of the resemblance of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals to the cherubs in Renaissance art.</p></div><div id="cherubism.Prevalence"><h3>Prevalence</h3><p>Prevalence is unknown. Approximately 300 cases have been reported in the medical literature. Variability of the cherubism <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> may result in underdiagnosis of the condition in children, and as bone remodeling occurs into adulthood, there may be no evidence of previous disease on imaging in adults despite the presence of a <i>SH3BP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="cherubism.Genetically_Related_Allelic_Di"><h3>Genetically Related (Allelic) Disorders</h3><p>No other phenotypes are known to be associated with pathogenic variants in <i>SH3BP2</i>.</p></div></div><div id="cherubism.Differential_Diagnosis"><h2 id="_cherubism_Differential_Diagnosis_">Differential Diagnosis</h2><div id="cherubism.T.disorders_to_consider_in_the" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Cherubism</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1137/table/cherubism.T.disorders_to_consider_in_the/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cherubism.T.disorders_to_consider_in_the_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features</th></tr><tr><th headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_4" id="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping</th><th headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_4" id="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing</th></tr></thead><tbody><tr><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">RASopathies&#x000a0;<sup>1</sup> including:
<ul><li class="half_rhythm"><div><a href="/books/n/gene/noonan/">Noonan syndrome</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/cfc/">Cardiofaciocutaneous syndrome</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/nf1/">Neurofibromatosis 1</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/leopard/">Noonan syndrome with multiple lentigines</a></div></li></ul>
</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BRAF</i><br /><i>MAP2K1</i><br /><i>NF1</i><br /><i>PTPN11</i><br /><i>SOS1</i><br /><i>KRAS</i><br /><i>LZTR1</i><br /><i>MAP2K2</i><br /><i>NRAS</i><br /><i>RAF1</i><br /><i>RASA2</i><br /><i>RRAS</i><br /><i>RIT1</i><br /><i>SOS2</i></td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cherubism.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Giant-cell lesions of bones &#x00026; soft tissues frequently found in jaws</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cherubism.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">RASopathies:
<ul><li class="half_rhythm"><div>Characteristic facial &#x00026; neurocutaneous findings</div></li><li class="half_rhythm"><div>Congenital anomalies in multiple systems</div></li></ul>
</td></tr><tr><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Central giant-cell granuloma&#x000a0;<sup>2</sup></td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>3</sup></td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cherubism.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Benign lesion usually occurring in mandible &#x00026; maxilla</div></li><li class="half_rhythm"><div>Histologically, central giant-cell granuloma cannot be separated from cherubism.</div></li></ul>
</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cherubism.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lesions in:
<ul><li class="half_rhythm"><div>Central giant-cell granuloma: most often unilocular</div></li><li class="half_rhythm"><div>Cherubism: usually multilocular</div></li></ul>
</td></tr><tr><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mccune-albright/">Fibrous Dysplasia / McCune-Albright Syndrome</a> (FD/MAS)</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GNAS1</i></td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 4</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cherubism.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Craniofacial form of FD/MAS may show clinical &#x00026; radiologic overlap w/cherubism &#x00026; thus be difficult to differentiate.&#x000a0;<sup>5</sup></td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cherubism.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fibrous dysplasia:
<ul><li class="half_rhythm"><div>Lesions affecting other body parts incl femur, tibia, or ribs (rarely seen in cherubism)</div></li><li class="half_rhythm"><div>Absence of typical symmetric swelling of lower face (typical of cherubism)</div></li><li class="half_rhythm"><div>On plain films, a characteristic ground-glass pattern</div></li></ul>
MAS:
<ul><li class="half_rhythm"><div>Caf&#x000e9; au lait macules</div></li><li class="half_rhythm"><div>Endocrine abnormalities</div></li><li class="half_rhythm"><div>Chronic bony involvement that does not resolve at puberty</div></li></ul>
</td></tr><tr><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hyperparathyroidism-jaw tumor (HPT-JT) syndrome (see <a href="/books/n/gene/hrpt2/"><i>CDC73</i>-Related Disorders</a>)</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CDC73</i></td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cherubism.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Benign ossifying fibromas of mandible or maxilla</div></li><li class="half_rhythm"><div>Occasionally bilateral/multifocal &#x00026; recurrent</div></li></ul>
</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cherubism.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">HPT-JT: hyperparathyroidism</td></tr><tr><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Familial <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> hyperparathyroidism<br />(OMIM <a href="https://omim.org/phenotypicSeries/PS145000" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS145000</a>)</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CDC73</i><br /><i>MEN1&#x000a0;<sup>6</sup></i><br /><i>CASR</i><br /><i>GCM2</i></td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cherubism.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Brown tumors (rare benign giant-cell lesions) resulting from parathyroid hormone effects on bone tissue in persons w/hyperparathyroidism</div></li><li class="half_rhythm"><div>Can occur in both maxilla &#x00026; mandible&#x000a0;<sup>7</sup></div></li></ul>
</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cherubism.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hyperparathyroidism: &#x02191; serum concentrations of calcium, parathyroid hormone, &#x00026; alkaline phosphatase&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ramon syndrome<br />(OMIM <a href="https://omim.org/entry/266270" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">266270</a>)</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cherubism.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gingival fibromatosis</td><td headers="hd_h_cherubism.T.disorders_to_consider_in_the_1_1_1_4 hd_h_cherubism.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ramon syndrome:
<ul><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Epilepsy</div></li><li class="half_rhythm"><div>Intellectual disability</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="cherubism.TF.2.1"><p class="no_margin">RASopathies refers to disorders of the RAS-MAPK pathway.</p></div></dd><dt>2. </dt><dd><div id="cherubism.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#cherubism.REF.de_lange.2005.464">De Lange &#x00026; Van den Akker [2005]</a></p></div></dd><dt>3. </dt><dd><div id="cherubism.TF.2.3"><p class="no_margin">A <a class="def" href="/books/n/gene/glossary/def-item/somatic-pathogenic-variant/">somatic pathogenic variant</a> in <i>SH3BP2</i> has been identified in one individual with central giant-cell granuloma [<a class="bk_pop" href="#cherubism.REF.carvalho.2009.106">Carvalho et al 2009</a>].</p></div></dd><dt>4. </dt><dd><div id="cherubism.TF.2.4"><p class="no_margin">Fibrous dysplasia / McCune-Albright syndrome, a sporadically occurring disorder, is caused by an early embryonic postzygotic somatic activating (<a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a>) <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GNAS</i> (encoding the cAMP pathway-associated G-protein, Gs&#x003b1;).</p></div></dd><dt>5. </dt><dd><div id="cherubism.TF.2.5"><p class="no_margin"><a class="bk_pop" href="#cherubism.REF.zohar.1989.340">Zohar et al [1989]</a></p></div></dd><dt>6. </dt><dd><div id="cherubism.TF.2.6"><p class="no_margin">Familial <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> hyperparathyroidism (FIHP) is characterized by parathyroid adenoma or hyperplasia without other associated endocrinopathies. Heterozygous <i>MEN1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants have been reported in 20% [<a class="bk_pop" href="#cherubism.REF.miedlich.2001.155">Miedlich et al 2001</a>, <a class="bk_pop" href="#cherubism.REF.villablanca.2002.313">Villablanca et al 2002</a>] to 57% [<a class="bk_pop" href="#cherubism.REF.pannett.2003.639">Pannett et al 2003</a>] of families with FIHP.</p></div></dd><dt>7. </dt><dd><div id="cherubism.TF.2.7"><p class="no_margin"><a class="bk_pop" href="#cherubism.REF.lessa.2005.432">Lessa et al [2005]</a></p></div></dd></dl></div></div></div><p>Cherubism has also been reported in (likely coincidental) association with a single case of coronal and sagittal craniosynostosis [<a class="bk_pop" href="#cherubism.REF.stiller.2000.325">Stiller et al 2000</a>].</p></div><div id="cherubism.Management"><h2 id="_cherubism_Management_">Management</h2><div id="cherubism.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with cherubism, the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Radiologic assessment to determine facial bone involvement. Computed tomography (CT utilizing the "as low as reasonably achievable" principle to minimize radiation) is currently the imaging modality most suitable to study bone lesions of the maxillofacial complex, enabling a precise evaluation of the components of the lesion [<a class="bk_pop" href="#cherubism.REF.pinheiro.2013.74">Pinheiro et al 2013</a>]. However, evaluation of lesions encroaching on neurovascular or ocular structures may require a multimodality approach, which includes MRI [<a class="bk_pop" href="#cherubism.REF.cordeiro.2016.134">Cordeiro et al 2016</a>, <a class="bk_pop" href="#cherubism.REF.purohit.2016.43">Purohit et al 2016</a>]. The MRI findings of individual cherubism lesions are not specific to lesions caused by mutations in <i>SH3BP2</i> [<a class="bk_pop" href="#cherubism.REF.beaman.2004.1051">Beaman et al 2004</a>, <a class="bk_pop" href="#cherubism.REF.jain.2006.1099">Jain &#x00026; Sharma 2006</a>].</div></li><li class="half_rhythm"><div>Evaluation in a craniofacial clinic including oral and maxillofacial surgery, plastic surgery, dentistry/orthodontics, otolaryngology, and child psychology or social work</div></li><li class="half_rhythm"><div>Orthodontic assessment to align tilted teeth is usually required after osseous growth is completed, but may be required concomitantly with fixed orthodontic appliances.</div></li><li class="half_rhythm"><div>Ophthalmologic examination</div></li><li class="half_rhythm"><div>Assessment of respiratory status including determining the presence or absence of mouth breathing, snoring, chronic nasal infection, and obstructive sleep apnea. An overnight polysomnogram should be considered if concerns regarding sleep-disordered breathing are present.</div></li><li class="half_rhythm"><div>Assessment by a speech therapist to include a swallowing assessment to determine if there is backward displacement of the tongue or obliteration of the nasal airway</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="cherubism.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment protocols for the complications of cherubism are not well established and are evolving due to recent advances in understanding the autoinflammatory nature of this bone disease. Given that cherubism is considered to be a self-limited condition that improves over time, treatment should be tailored to the individual's presentation and the evolution of the disease. Depending on the severity, surgery may be needed for functional and esthetic concerns.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Children with cherubism</b> should be referred to a craniofacial clinic with pediatric experience for ongoing management. A craniofacial clinic associated with a major pediatric medical center usually includes a surgical team, dentist, orthodontic specialist, ophthalmologist, and child psychologist or social worker.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Surgical interventions</b> include curettage with or without bone grafting [<a class="bk_pop" href="#cherubism.REF.kozakiewicz.2001.123">Kozakiewicz et al 2001</a>, <a class="bk_pop" href="#cherubism.REF.roginsky.2009.218">Roginsky et al 2009</a>]. Liposuction has also been used successfully to re-contour the jaws. Surgical interventions are likely to occur between ages five and 15 years in individuals with disfiguring enlargement of jaws or locally aggressive lesions associated with complications such as impaired swallowing, respiratory issues, nasal airway obstruction, or tongue displacement.</div><div class="half_rhythm">Surgical therapy needs to be individually tailored and not create unrealistic expectations since recurrence of the lesions is possible and surgery may not halt disease progression [<a class="bk_pop" href="#cherubism.REF.friedrich.2016.3109">Friedrich et al 2016</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Orthodontic treatment</b> is commonly required as the jaw distortion leads to permanent dental abnormalities including a malocclusive bite, premature loss of deciduous teeth, and widely spaced, misplaced, unerupted, or absent permanent teeth.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Ophthalmologic treatment</b> is necessary in rare individuals in whom orbital manifestations such as lower lid retraction, proptosis, diplopia, globe displacement, and visual loss caused by optic atrophy are present.</div></li><li class="half_rhythm"><div class="half_rhythm">Speech and language therapy may be necessary in rare cases where physical obstruction to the production of speech or swallowing is present.</div></li></ul></div><div id="cherubism.Surveillance"><h3>Surveillance</h3><p>Surveillance may reduce the risk for secondary complications such as visual impairment, upper airway obstruction, obstructive sleep apnea, and tooth displacement. Long-term follow up including clinical, radiographic, dental, orthodontic, and ophthalmologic evaluations is indicated [<a class="bk_pop" href="#cherubism.REF.silva.2007.567">Silva et al 2007</a>]. Expert-authored guidelines recommend annual reviews while new cysts continue to form or established cysts enlarge; after the disorder becomes quiescent, follow up every two to five years is recommended [<a class="bk_pop" href="#cherubism.REF.papadaki.2012.s6">Papadaki et al 2012</a>].</p></div><div id="cherubism.Evaluation_of_Relatives_at_Ris"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic at-risk relatives in order to identify as early as possible those who would benefit from surveillance and early intervention. Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known.</div></li><li class="half_rhythm"><div>Clinical and radiographic evaluations if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is not known.</div></li></ul><p>See <a href="#cherubism.Related_Genetic_Counseling_Iss">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cherubism.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="cherubism.Genetic_Counseling"><h2 id="_cherubism_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="cherubism.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Cherubism is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="cherubism.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Some individuals diagnosed with cherubism have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>Most individuals diagnosed with cherubism represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) and are presumed to have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Though theoretically possible, no instances of germline mosaicism have been reported.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with cherubism may appear to be negative because of failure to recognize the disorder in family members, reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, or a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed unless <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li><li class="half_rhythm"><div>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or is known to have the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the proband, the risk to sibs of inheriting the pathogenic variant is 50%. Variable expressivity and reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> have been observed in cherubism.</div></li><li class="half_rhythm"><div>If the <i>SH3BP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#cherubism.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li><li class="half_rhythm"><div>If the parents have not been tested for the <i>SH3BP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low. However, the sibs of a proband with clinically unaffected parents are still at increased risk for cherubism because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent or the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with cherubism has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>SH3BP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and/or is clinically <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</p></div><div id="cherubism.Related_Genetic_Counseling_Iss"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#cherubism.Evaluation_of_Relatives_at_Ris">Evaluation of Relatives at Risk</a> for information on testing at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, it is likely that the proband has a <i>de novo</i> pathogenic variant. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cherubism.Prenatal_Testing_and_Preimplan"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>SH3BP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="cherubism.Resources"><h2 id="_cherubism_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=cherubism" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Cherubism</a></div></li><li class="half_rhythm"><div><b>Children's Craniofacial Association (CCA)</b></div><div>13140 Coit Road</div><div>Suite 517</div><div>Dallas TX 75240</div><div><b>Phone:</b> 800-535-3643 (toll-free)</div><div><b>Email:</b> contactCCA@ccakids.com</div><div><a href="https://ccakids.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ccakids.org</a></div></li><li class="half_rhythm"><div><b>Face Equality International</b></div><div>United Kingdom</div><div><b>Email:</b> info@faceequalityinternational.org</div><div><a href="https://faceequalityinternational.org/thealliance/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.faceequalityinternational.org</a></div></li><li class="half_rhythm"><div><b>Fibrous Dysplasia Foundation</b></div><div><b>Email:</b> info@fibrousdysplasia.org</div><div><a href="http://fibrousdysplasia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.fibrousdysplasia.org</a></div></li></ul></div><div id="cherubism.Molecular_Genetics"><h2 id="_cherubism_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="cherubism.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Cherubism: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1137/table/cherubism.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cherubism.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_cherubism.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_cherubism.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_cherubism.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_cherubism.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_cherubism.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_cherubism.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_cherubism.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6452" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SH3BP2</i></a></td><td headers="hd_b_cherubism.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6452" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">4p16<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_cherubism.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P78314" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SH3 domain-binding protein 2</a></td><td headers="hd_b_cherubism.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SH3BP2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SH3BP2 database</a></td><td headers="hd_b_cherubism.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SH3BP2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SH3BP2</a></td><td headers="hd_b_cherubism.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SH3BP2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SH3BP2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="cherubism.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="cherubism.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Cherubism (<a href="/omim/118400,602104" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1137/table/cherubism.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cherubism.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/118400" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">118400</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHERUBISM</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602104" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602104</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SH3 DOMAIN-BINDING PROTEIN 2; SH3BP2</td></tr></tbody></table></div></div><p><b>Gene structure.</b> The <i>SH3BP2</i> transcript spans approximately 2.4 kb and comprises 13 exons. The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> was identified in a search for candidate tumor suppressor genes [<a class="bk_pop" href="#cherubism.REF.bell.1997.163">Bell et al 1997</a>]. For a detailed summary of gene and protein information, see <a href="/books/NBK1137/#cherubism.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Sequence analysis of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 9 of <i>SH3BP2</i> detects an estimated 80% of pathogenic variants in individuals tested [<a class="bk_pop" href="#cherubism.REF.ueki.2001.125">Ueki et al 2001</a>, <a class="bk_pop" href="#cherubism.REF.reichenberger.2012.s5">Reichenberger et al 2012</a>]. Reported pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> that mainly cluster within a six-amino-acid sequence from p.Arg415 to p.Gly420. Pathogenic variants in remaining exons are rare [<a class="bk_pop" href="#cherubism.REF.ueki.2001.125">Ueki et al 2001</a>, <a class="bk_pop" href="#cherubism.REF.lo.2003.37">Lo et al 2003</a>, <a class="bk_pop" href="#cherubism.REF.lietman.2006.717">Lietman et al 2006</a>]. A pathogenic missense variant in exon 4 in the pleckstrin homology <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> has been described by <a class="bk_pop" href="#cherubism.REF.carvalho.2009.106">Carvalho et al [2009]</a> in an individual with cherubism.</p><div id="cherubism.T.sh3bp2_pathogenic_variants_d" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>SH3BP2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1137/table/cherubism.T.sh3bp2_pathogenic_variants_d/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cherubism.T.sh3bp2_pathogenic_variants_d_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cherubism.T.sh3bp2_pathogenic_variants_d_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cherubism.T.sh3bp2_pathogenic_variants_d_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cherubism.T.sh3bp2_pathogenic_variants_d_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cherubism.T.sh3bp2_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1253C&#x0003e;G</td><td headers="hd_h_cherubism.T.sh3bp2_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro418Arg</td><td headers="hd_h_cherubism.T.sh3bp2_pathogenic_variants_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_003023.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003023<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_003014.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_003014<wbr style="display:inline-block"></wbr>​.3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SH3BP2</i> encodes the adaptor protein SH3-<a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> binding protein 2 (3BP-2), which is required in several intracellular protein tyrosine kinase-dependent signaling pathways during hematopoietic cell differentiation and function [<a class="bk_pop" href="#cherubism.REF.foucault.2005.1106">Foucault et al 2005</a>]. 3BP-2 positively regulates the activity of the <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a> NFAT, which is involved in osteoclastogenesis [<a class="bk_pop" href="#cherubism.REF.lietman.2008.644">Lietman et al 2008</a>]. 3BP-2 contains the following:</p><ul><li class="half_rhythm"><div>An N-terminal pleckstrin homology (PH) <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a></div></li><li class="half_rhythm"><div>A proline-rich stretch that binds to Src holomolgy (SH) 3 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>-containing proteins</div></li><li class="half_rhythm"><div>A C-terminal SH2 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> that binds to phosphotyrosine residues [<a class="bk_pop" href="#cherubism.REF.deckert.2006.1081">Deckert 2006</a>]</div></li></ul><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Cherubism results from pathogenic variants that are primarily clustered within peptide sequence RSPPDG lying between the PH and SH2 domains. It is unclear how abnormal 3BP-2 causes excessive bone resorption and soft tissue proliferation primarily restricted to the jaws, and why cherubism lesions regress after puberty. A knock-in mouse model with the most common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in human 3BP-2 (p.Pro418Arg) develops severe osteoporosis associated with highly activated osteoclasts, demonstrating that pathogenic variants within this peptide sequence result in a <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> activity [<a class="bk_pop" href="#cherubism.REF.ueki.2007.71">Ueki et al 2007</a>, <a class="bk_pop" href="#cherubism.REF.wang.2010.1306">Wang et al 2010</a>].</p><p>It has been proposed that the bone autoinflammation is the result of toll-like receptors (TLR) reacting to oral flora and damage-associated molecular patterns during jaw remodeling. Cherubism lesions usually begin to regress after puberty by mechanisms that may involve the TLR-myeloid differentiation primary response 88 (MYD88) pathway [<a class="bk_pop" href="#cherubism.REF.yoshitaka.2014.1752">Yoshitaka et al 2014</a>, <a class="bk_pop" href="#cherubism.REF.prodhomme.2015.1396">Prod'Homme et al 2015</a>].</p></div><div id="cherubism.References"><h2 id="_cherubism_References_">References</h2><div id="cherubism.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.ahmadi.2003.570">Ahmadi AJ, Pirinjian GE, Sires BS. Optic neuropathy and macular chorioretinal folds caused by orbital cherubism. <span><span class="ref-journal">Arch Ophthalmol. </span>2003;<span class="ref-vol">121</span>:570–3.</span> [<a href="/pubmed/12695257" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12695257</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.anderson.1962.5">Anderson DE, McClendon JL. Cherubism-hereditary fibrous dysplasia of the jaws; genetic considerations. <span><span class="ref-journal">Oral Surg Oral Med Oral Pathol. </span>1962;<span class="ref-vol">15</span> Suppl 2:5–16.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.badermeunier.2018.606">Bader-Meunier B, Van Nieuwenhove E, Breton S, Wouters C. Bone involvement in monogenic autoinflammatory syndromes. <span><span class="ref-journal">Rheumatology (Oxford). </span>2018;<span class="ref-vol">57</span>:606–18.</span> [<a href="/pubmed/28968889" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28968889</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.battaglia.2000.573">Battaglia A, Merati A, Magit A. Cherubism and upper airway obstruction. <span><span class="ref-journal">Otolaryngol Head Neck Surg. </span>2000;<span class="ref-vol">122</span>:573–4.</span> [<a href="/pubmed/10740181" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10740181</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.beaman.2004.1051">Beaman FD, Bancroft LW, Peterson JJ, Kransdorf MJ, Murphey MD, Menke DM. Imaging characteristics of cherubism. <span><span class="ref-journal">AJR Am J Roentgenol. </span>2004;<span class="ref-vol">182</span>:1051–4.</span> [<a href="/pubmed/15039186" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15039186</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.bell.1997.163">Bell SM, Shaw M, Jou YS, Myers RM, Knowles MA. Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer. <span><span class="ref-journal">Genomics. </span>1997;<span class="ref-vol">44</span>:163–70.</span> [<a href="/pubmed/9299232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9299232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.carroll.2001.38">Carroll AL, Sullivan TJ. Orbital involvement in cherubism. <span><span class="ref-journal">Clin Experiment Ophthalmol. </span>2001;<span class="ref-vol">29</span>:38–40.</span> [<a href="/pubmed/11272784" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11272784</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.carvalho.2009.106">Carvalho VM, Perdig&#x000e3;o PF, Amaral FR, de Souza PEA, De Marco L, Gomez RS. Novel mutations in the SH3BP2 gene associated with sporadic central giant lesions and cherubism. <span><span class="ref-journal">Oral Dis. </span>2009;<span class="ref-vol">15</span>:106–10.</span> [<a href="/pubmed/19017279" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19017279</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.colombo.2001.1884">Colombo F, Cursiefen C, Neukam FW, Holbach LM. Orbital involvement in cherubism. <span><span class="ref-journal">Ophthalmology. </span>2001;<span class="ref-vol">108</span>:1884–8.</span> [<a href="/pubmed/11581066" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11581066</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.cordeiro.2016.134">Cordeiro MS, Backes AR, J&#x000fa;nior AF, Gon&#x000e7;alves EH, de Oliveira JX. Fibrous dysplasia characterization using lacunarity analysis. <span><span class="ref-journal">J Digit Imaging. </span>2016;<span class="ref-vol">29</span>:134–40.</span> [<a href="/pmc/articles/PMC4722029/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4722029</span></a>] [<a href="/pubmed/26307180" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26307180</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.davis.1983.119">Davis GB, Sinn DP, Watson SW. Case 43, part II: Cherubism. <span><span class="ref-journal">J Oral Maxillofac Surg. </span>1983;<span class="ref-vol">41</span>:119–20.</span> [<a href="/pubmed/6571880" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6571880</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.de_lange.2005.464">De Lange J, Van den Akker HP. Clinical and radiological features of central giant-cell lesions of the jaw. <span><span class="ref-journal">Oral Surg Oral Med Oral Pathol Oral Radiol Endod. </span>2005;<span class="ref-vol">99</span>:464–70.</span> [<a href="/pubmed/15772595" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15772595</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.deckert.2006.1081">Deckert M. [The adaptor protein 3BP2 in leukocyte signaling]. Article in French. <span><span class="ref-journal">Med Sci (Paris). </span>2006;<span class="ref-vol">22</span>:1081–6.</span> [<a href="/pubmed/17156730" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17156730</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.fonseca.2004.75">Fonseca LC, de Freitas JB, Maciel PH, Cavalcanti MG. Temporal bone involvement in cherubism: case report. <span><span class="ref-journal">Braz Dent J. </span>2004;<span class="ref-vol">15</span>:75–8.</span> [<a href="/pubmed/15322650" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15322650</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.font.2003.1846">Font RL, Blanco G, Soparkar CN, Patrinely JR, Ostrowski ML. Giant cell reparative granuloma of the orbit associated with cherubism. <span><span class="ref-journal">Ophthalmology. </span>2003;<span class="ref-vol">110</span>:1846–9.</span> [<a href="/pubmed/13129888" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13129888</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.foucault.2005.1106">Foucault I, Le Bras S, Charvet C, Moon C, Altman A, Deckert M. The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor. <span><span class="ref-journal">Blood. </span>2005;<span class="ref-vol">105</span>:1106–13.</span> [<a href="/pubmed/15345594" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15345594</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.friedrich.2016.3109">Friedrich RE, Scheuer HA, Zustin J, Grob T. Cherubism: a case report with surgical intervention. <span><span class="ref-journal">Anticancer Res. </span>2016;<span class="ref-vol">36</span>:3109–15.</span> [<a href="/pubmed/27272835" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27272835</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.gomes.2005.313">Gomes MF, de Souza Setubal Destro MF, de Freitas Banzi EC, dos Santos SH, Claro FA, de Oliveira Nogueira T. Aggressive behaviour of cherubism in a teenager: 4-years of clinical follow-up associated with radiographic and histological features. <span><span class="ref-journal">Dentomaxillofac Radiol. </span>2005;<span class="ref-vol">34</span>:313–8.</span> [<a href="/pubmed/16120883" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16120883</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.jain.2006.1099">Jain V, Sharma R. Radiographic, CT and MRI features of cherubism. <span><span class="ref-journal">Pediatr Radiol. </span>2006;<span class="ref-vol">36</span>:1099–104.</span> [<a href="/pubmed/16847596" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16847596</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.jones.1933.946">Jones WA. Familial multilocular cystic disease of the jaws. <span><span class="ref-journal">Am J Cancer. </span>1933;<span class="ref-vol">17</span>:946.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.jones.1950.334">Jones WA, Gerrie J, Pritchard J. Cherubism &#x02013; familial fibrous dysplasia of the jaws. <span><span class="ref-journal">J Bone Joint Surg Br. </span>1950;<span class="ref-vol">32-B</span>(3):334–47.</span> [<a href="/pubmed/14778852" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14778852</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.kadlub.2016.62">Kadlub N, Sessiecq Q, Dainese L, Joly A, Lehalle D, Marlin S, Badoual C, Galmiche L, Majoufre-Lefebvre C, Berdal A, Deckert M, Vazquez M, Descroix V, Coudert AE, Picard A. Defining a new aggressiveness classification and using NFATc1 localization as a prognostic factor in cherubism. <span><span class="ref-journal">Hum Pathol. </span>2016;<span class="ref-vol">58</span>:62–71.</span> [<a href="/pubmed/27498064" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27498064</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.kadlub.2015.878">Kadlub N, Vazquez MP, Galmiche L, L'Hermin&#x000e9; AC, Dainese L, Ulinski T, Fauroux B, Pavlov I, Badoual C, Marlin S, Deckert M, Leboulanger N, Berdal A, Descroix V, Picard A, Coudert AE. The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. <span><span class="ref-journal">J Bone Miner Res. </span>2015;<span class="ref-vol">30</span>:878–85.</span> [<a href="/pubmed/25491283" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25491283</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.khirani.2013.927">Khirani S, Kadlub N, Delord V, Picard A, Fauroux B. Nocturnal mouthpiece ventilation and medical hypnosis to treat severe obstructive sleep apnea in a child with cherubism. <span><span class="ref-journal">Pediatr Pulmonol. </span>2013;<span class="ref-vol">48</span>:927–9.</span> [<a href="/pubmed/23129383" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23129383</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.kozakiewicz.2001.123">Kozakiewicz M, Perczynska-Partyka W, Kobos J. Cherubism--clinical picture and treatment. <span><span class="ref-journal">Oral Dis. </span>2001;<span class="ref-vol">7</span>:123–30.</span> [<a href="/pubmed/11355438" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11355438</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.ladhani.2003.552">Ladhani S, Sundaram P, Joshi JM. Sleep disordered breathing in an adult with cherubism. <span><span class="ref-journal">Thorax. </span>2003;<span class="ref-vol">58</span>:552.</span> [<a href="/pmc/articles/PMC1746697/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1746697</span></a>] [<a href="/pubmed/12775879" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12775879</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.lessa.2005.432">Lessa MM, Sakae FA, Tsuji RK, Filho BC, Voegels RL, Butugan O. Brown tumor of the facial bones: case report and literature review. <span><span class="ref-journal">Ear Nose Throat J. </span>2005;<span class="ref-vol">84</span>:432–4.</span> [<a href="/pubmed/16813033" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16813033</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.li.2006.84">Li CY, Yu SF. A novel mutation in the SH3BP2 gene causes cherubism: case report. <span><span class="ref-journal">BMC Med Genet. </span>2006;<span class="ref-vol">7</span>:84.</span> [<a href="/pmc/articles/PMC1764878/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1764878</span></a>] [<a href="/pubmed/17147794" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17147794</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.lietman.2006.717">Lietman SA, Kalinchinko N, Deng X, Kohanski R, Levine MA. Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation. <span><span class="ref-journal">Hum Mutat. </span>2006;<span class="ref-vol">27</span>:717–8.</span> [<a href="/pubmed/16786512" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16786512</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.lietman.2008.644">Lietman SA, Yin L, Levine MA. SH3BP2 is an activator of NFAT activity and osteoclastogenesis. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2008;<span class="ref-vol">371</span>:644–8.</span> [<a href="/pmc/articles/PMC2760267/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2760267</span></a>] [<a href="/pubmed/18440306" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18440306</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.ling.2015.681">Ling E, Zeltser R, Makarov V. A case of cherubism with spondyloarthropathy. <span><span class="ref-journal">Int J Rheum Dis. </span>2015;<span class="ref-vol">18</span>:681–4.</span> [<a href="/pubmed/25960037" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25960037</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.lo.2003.37">Lo B, Faiyaz-Ul-Haque M, Kennedy S, Aviv R, Tsui LC, Teebi AS. Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">121A</span>:37–40.</span> [<a href="/pubmed/12900899" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12900899</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.miedlich.2001.155">Miedlich S, Lohmann T, Schneyer U, Lamesch P, Paschke R. Familial isolated primary hyperparathyroidism--a multiple endocrine neoplasia type 1 variant? <span><span class="ref-journal">Eur J Endocrinol. </span>2001;<span class="ref-vol">145</span>:155–60.</span> [<a href="/pubmed/11454510" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11454510</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.mirmohammadsadeghi.2015.33">Mirmohammadsadeghi A, Eshraghi B, Shahsanaei A, Assari R. Cherubism: report of three cases and literature review. <span><span class="ref-journal">Orbit. </span>2015;<span class="ref-vol">34</span>:33–7.</span> [<a href="/pubmed/25264591" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25264591</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.morbach.2013.185">Morbach H, Hedrich CM, Beer M, Girschick HJ. Autoinflammatory bone disorders. <span><span class="ref-journal">Clin Immunol. </span>2013;<span class="ref-vol">147</span>:185–96.</span> [<a href="/pubmed/23369460" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23369460</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.ozkan.2003.1005">Ozkan Y, Varol A, Turker N, Aksakalli N, Basa S. Clinical and radiological evaluation of cherubism: a sporadic case report and review of the literature. <span><span class="ref-journal">Int J Pediatr Otorhinolaryngol. </span>2003;<span class="ref-vol">67</span>:1005–12.</span> [<a href="/pubmed/12907058" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12907058</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.pannett.2003.639">Pannett AA, Kennedy AM, Turner JJ, Forbes SA, Cavaco BM, Bassett JH, Cianferotti L, Harding B, Shine B, Flinter F, Maidment CG, Trembath R, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2003;<span class="ref-vol">58</span>:639–46.</span> [<a href="/pubmed/12699448" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12699448</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.papadaki.2012.s6">Papadaki ME, Lietman SA, Levine MA, Olsen BR, Kaban LB, Reichenberger EJ. Cherubism: best clinical practice. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2012;<span class="ref-vol">7</span>:S6.</span> [<a href="/pmc/articles/PMC3359956/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3359956</span></a>] [<a href="/pubmed/22640403" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22640403</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.pinheiro.2013.74">Pinheiro LR, Pinheiro JJ, J&#x000fa;nior SA, Guerreiro N, Cavalcanti MG. Clinical and imagiological findings of central giant cell lesion and cherubism. <span><span class="ref-journal">Braz Dent J. </span>2013;<span class="ref-vol">24</span>:74–9.</span> [<a href="/pubmed/23657418" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23657418</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.pontes.2007.831">Pontes FS, Ferreira AC, Kato AM, Pontes HA, Almeida DS, Rodini CO, Pinto DS Jr. Aggressive case of cherubism: 17-year follow up. <span><span class="ref-journal">Int J Pediatr Otorhinolaryngol. </span>2007;<span class="ref-vol">71</span>:831–5.</span> [<a href="/pubmed/17360048" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17360048</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.preda.2010.87">Preda L, Dinca O, Bucur A, Dragomir C, Severin E. Identical mutation in SH3BP2 gene causes clinical phenotypes with different severity in mother and daughter - case report. <span><span class="ref-journal">Mol Syndromol. </span>2010;<span class="ref-vol">1</span>:87–90.</span> [<a href="/pmc/articles/PMC2941844/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2941844</span></a>] [<a href="/pubmed/21045962" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21045962</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.prescott.2013.131">Prescott T, Redfors M, Rustad CF, Eiklid KL, Geirdal A&#x000d8;, Storhaug K, Jensen JL. Characterization of a Norwegian cherubism cohort; molecular genetic findings, oral manifestations and quality of life. <span><span class="ref-journal">Eur J Med Genet. </span>2013;<span class="ref-vol">56</span>:131–7.</span> [<a href="/pubmed/23298620" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23298620</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.prodhomme.2015.1396">Prod'Homme V, Boyer L, Dubois N, Mallavialle A, Munro P, Mouska X, Coste I, Rottapel R, Tartare-Deckert S, Deckert M. Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages. <span><span class="ref-journal">J Clin Invest. </span>2015;<span class="ref-vol">125</span>:1396–400.</span> [<a href="/pmc/articles/PMC4396483/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4396483</span></a>] [<a href="/pubmed/25705883" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25705883</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.purohit.2016.43">Purohit BS, Vargas MI, Ailianou A, Merlini L, Poletti PA, Platon A, Delattre BM, Rager O, Burkhardt K, Becker M. Orbital tumours and tumour-like lesions: exploring the armamentarium of multiparametric imaging. <span><span class="ref-journal">Insights Imaging. </span>2016;<span class="ref-vol">7</span>:43–68.</span> [<a href="/pmc/articles/PMC4729705/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4729705</span></a>] [<a href="/pubmed/26518678" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26518678</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.redfors.2013.20130034">Redfors M, Jensen JL, Storhaug K, Prescott T, Larheim TA. Cherubism: panoramic and CT features in adults. <span><span class="ref-journal">Dentomaxillofac Radiol. </span>2013;<span class="ref-vol">42</span>:20130034.</span> [<a href="/pmc/articles/PMC3853512/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3853512</span></a>] [<a href="/pubmed/24048692" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24048692</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.reichenberger.2012.s5">Reichenberger EJ, Levine MA, Olsen BR, Papadaki ME, Lietman SA. The role of SH3BP2 in the pathophysiology of cherubism. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2012;<span class="ref-vol">7</span>:S5.</span> [<a href="/pmc/articles/PMC3359958/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3359958</span></a>] [<a href="/pubmed/22640988" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22640988</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.roginsky.2009.218">Roginsky VV, Ivanov AL, Ovtchinnikov A, Khonari RH. Familial cherubism: the experience of the Moscow Central Institute for Stomatology and Maxillo-Facial Surgery. <span><span class="ref-journal">Int J Oral Maxillofac Surg. </span>2009;<span class="ref-vol">38</span>:218–23.</span> [<a href="/pubmed/19038533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19038533</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.schultzemosgau.2003.201">Schultze-Mosgau S, Holbach LM, Wiltfang J. Cherubism: clinical evidence and therapy. <span><span class="ref-journal">J Craniofac Surg. </span>2003;<span class="ref-vol">14</span>:201–6.</span> [<a href="/pubmed/12621291" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12621291</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.silva.2002.45">Silva EC, de Souza PE, Barreto DC, Dias RP, Gomez RS. An extreme case of cherubism. <span><span class="ref-journal">Br J Oral Maxillofac Surg. </span>2002;<span class="ref-vol">40</span>:45–8.</span> [<a href="/pubmed/11883969" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11883969</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.silva.2007.567">Silva GC, Gomez RS, Vieira TC, Silva EC. Cherubism: long-term follow-up of 2 patients in whom it regressed without treatment. <span><span class="ref-journal">Br J Oral Maxillofac Surg. </span>2007;<span class="ref-vol">45</span>:567–70.</span> [<a href="/pubmed/17030358" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17030358</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.stiller.2000.325">Stiller M, Urban M, Golder W, Tiziani V, Reichenberger E, Frege J, Opitz C, Peters H. Craniosynostosis in cherubism. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">95</span>:325–31.</span> [<a href="/pubmed/11186885" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11186885</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.stoor.2017.1806">Stoor P, Suomalainen A, Kemola M, Atre S. Craniofacial and dental features in six children with cherubism. <span><span class="ref-journal">J Craniofac Surg. </span>2017;<span class="ref-vol">28</span>:1806–11.</span> [<a href="/pubmed/28857986" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28857986</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.timo_ca.2000.336">Timo&#x0015f;ca GC, G&#x00103;le&#x0015f;anu RM, Cotu&#x00163;iu C, Grigora&#x0015f; M. Aggressive form of cherubism: report of a case. <span><span class="ref-journal">J Oral Maxillofac Surg. </span>2000;<span class="ref-vol">58</span>:336–44.</span> [<a href="/pubmed/10716121" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10716121</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.ueki.2007.71">Ueki Y, Lin CY, Senoo M, Ebihara T, Agata N, Onji M, Saheki Y, Kawai T, Mukherjee PM, Reichenberger E, Olsen BR. Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice. <span><span class="ref-journal">Cell. </span>2007;<span class="ref-vol">128</span>:71–83.</span> [<a href="/pubmed/17218256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17218256</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.ueki.2001.125">Ueki Y, Tiziani V, Santanna C, Fukai N, Maulik C, Garfinkle J, Ninomiya C, doAmaral C, Peters H, Habal M, Rhee-Morris L, Doss JB, Kreiborg S, Olsen BR, Reichenberger E. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">28</span>:125–6.</span> [<a href="/pubmed/11381256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11381256</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.villablanca.2002.313">Villablanca A, Wassif WS, Smith T, H&#x000f6;&#x000f6;g A, Vierimaa O, Kassem M, Dwight T, Forsberg L, Du Q, Learoyd D, Jones K, Stranks S, Juhlin C, Teh BT, Carling T, Robinson B, Larsson C. Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism. <span><span class="ref-journal">Eur J Endocrinol. </span>2002;<span class="ref-vol">147</span>:313–22.</span> [<a href="/pubmed/12213668" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12213668</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.von_wowern.2000.765">Von Wowern N. Cherubism: a 36-year long-term follow-up of 2 generations in different families and review of the literature. <span><span class="ref-journal">Oral Surg Oral Med Oral Pathol Oral Radiol Endod. </span>2000;<span class="ref-vol">90</span>:765–72.</span> [<a href="/pubmed/11113824" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11113824</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.wang.2010.1306">Wang CJ, Chen IP, Koczon-Jaremko B, Boskey AL, Ueki Y, Khun L, Reichenberger EJ. Pro416Arg cherubism mutation in sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties. <span><span class="ref-journal">Bone. </span>2010;<span class="ref-vol">46</span>:1306–15.</span> [<a href="/pmc/articles/PMC2854251/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2854251</span></a>] [<a href="/pubmed/20117257" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20117257</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.wang.2006.322">Wang CN, Song YL, Peng B, Lu DH, Fan MW, Li J, Ye XQ, Fan HL, Bian Z. The aggressive form of cherubism: report of two cases in unrelated families. <span><span class="ref-journal">Br J Oral Maxillofac Surg. </span>2006;<span class="ref-vol">44</span>:322–4.</span> [<a href="/pubmed/16310907" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16310907</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.wayman.1978.47">Wayman JB. Cherubism: a report on three cases. <span><span class="ref-journal">British Journal of Oral Surgery. </span>1978;<span class="ref-vol">16</span>:47–56.</span> [<a href="/pubmed/280370" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 280370</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.wipff.2011.555">Wipff J, Adamsbaum C, Kahan A, Job-Deslandre C. Chronic recurrent multifocal osteomyelitis. <span><span class="ref-journal">Joint Bone Spine. </span>2011;<span class="ref-vol">78</span>:555–60.</span> [<a href="/pubmed/21441060" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21441060</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.wright.2017.j4068">Wright V. What it feels like to have a facial disfigurement. <span><span class="ref-journal">BMJ. </span>2017;<span class="ref-vol">358</span>:j4068.</span> [<a href="/pubmed/28903929" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28903929</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.yoo.2015.70">Yoo SH, Pineles SL, Jarrahy R, Velez FG. Ophthalmic manifestations of cherubism. <span><span class="ref-journal">J AAPOS. </span>2015;<span class="ref-vol">19</span>:70–2.</span> [<a href="/pmc/articles/PMC4503315/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4503315</span></a>] [<a href="/pubmed/25727591" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25727591</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.yoshitaka.2014.1752">Yoshitaka T, Mukai T, Kittaka M, Alford LM, Masrani S, Ishida S, Yamaguchi K, Yamada M, Mizuno N, Olsen BR, Reichenberger EJ, Ueki Y. Enhanced TLR-MYD88 signaling stimulates autoinflammation in SH3BP2 cherubism mice and defines the etiology of cherubism. <span><span class="ref-journal">Cell Rep. </span>2014;<span class="ref-vol">8</span>:1752–66.</span> [<a href="/pmc/articles/PMC4177302/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4177302</span></a>] [<a href="/pubmed/25220465" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25220465</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cherubism.REF.zohar.1989.340">Zohar Y, Grausbord R, Shabtai F, Talmi Y. Fibrous dysplasia and cherubism as an hereditary familial disease. Follow-up of four generations. <span><span class="ref-journal">J Craniomaxillofac Surg. </span>1989;<span class="ref-vol">17</span>:340–4.</span> [<a href="/pubmed/2592573" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2592573</span></a>]</div></li></ul></div></div><div id="cherubism.Chapter_Notes"><h2 id="_cherubism_Chapter_Notes_">Chapter Notes</h2><div id="cherubism.Author_History"><h3>Author History</h3><p>Berivan Baskin, PhD, FCCMG, FACMG (2007-present)<br />Sarah Bowdin, BM, MSc, MRCPCH (2011-present)<br />Peter Kannu, MB ChB, PhD, DCH, FRACP, FRCPC (2018-present)<br />Peter N Ray, PhD, FCCMG, FACMG; University of Toronto (2007-2018)<br />Ahmad Teebi, MD, FRCPC, FACMG; Weill Cornell Medical College - Qatar (2007-2011)</p></div><div id="cherubism.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>21 November 2018 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>1 September 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>26 February 2007 (me) Review posted live</div></li><li class="half_rhythm"><div>8 December 2006 (pr) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1137</span><span class="label">PMID: <a href="/pubmed/20301316" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301316</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/chediak-higashi/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cach/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1137&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1137/?report=reader">PubReader</a></li><li><a href="/books/NBK1137/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1137" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1137" style="display:none" title="Cite this Page"><div class="bk_tt">Kannu P, Baskin B, Bowdin S. Cherubism. 2007 Feb 26 [Updated 2018 Nov 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1137/pdf/Bookshelf_NBK1137.pdf">PDF version of this page</a> (457K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cherubism.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cherubism.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#cherubism.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#cherubism.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#cherubism.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cherubism.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cherubism.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cherubism.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#cherubism.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cherubism.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6452[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SH3BP2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1488616" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1488616" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1488616" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1488616" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301744" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CDC73</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CDC73</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hyde SM, Rich TA, Waguespack SG, Perrier ND, Hu MI. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301368" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Saethre-Chotzen Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Saethre-Chotzen Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gallagher ER, Ratisoontorn C, Cunningham ML. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301510" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dietz H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301575" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mehta PA, Tolar J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301512" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hypokalemic Periodic Paralysis</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hypokalemic Periodic Paralysis<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Weber F, Lehmann-Horn F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301316" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301316" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc942add21425a25e27c0e">Cherubism - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Cherubism - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:28:10-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89303FDFC89A4100000000054E026C&amp;ncbi_session=CE89303FDFC94291_1358SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1137%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1137&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1137/&amp;ncbi_pagename=Cherubism - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89303FDFC94291_1358SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>